Latest Post

July 10, 2020

Mitigating Risk in Pharmaceutical Manufacturing with Visually-Inspected Components

<p><span>The overall quality of a final drug product depends on the components of its packaging and delivery systems.&nbsp; The use of visually inspected components reduces the risk of defective components and helps ensure patient safety.</span></p>
Olga Laskina

Olga Laskina, Ph.D.

Sr. Technical Account Specialist, NA

Previous Posts
Plungers Vision Inspection

June 26, 2018

Inspecting Elastomer Components: Can You Spot a Defect?

Bill Matakas

Bill Matakas

Sr. Director, Product Management & Marketing Operations

elastomer component defect rate on finished drug product

October 19, 2015

Looking for Ways to Reduce End of Line Rejects Significantly

West Pharma

Bjoern Henze, Ph.D.

Manager, Technical Customer Support, Commercial